Page 689 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 689

CHAPTER 31  Tumors of the Nervous System  667


           syringomyelic syndrome (see Fig. 31.6). 135  All types of SC tumors   Diagnosis of Spinal Cord Tumors
           can cause numerous secondary changes within the SC including   The minimum database for a patient with a suspected SC neo-
           edema, inflammation, gliosis, and hemorrhage. Signs of paraspinal
  VetBooks.ir  hyperesthesia arise from compression, stretching, inflammation,   plasm is identical to that for a brain tumor patient. Although these
                                                                 laboratory tests will seldom provide a definitive answer regarding
           or invasion of the meninges, nerve roots, periosteum, or paraspi-
           nal musculature. Early reports have described IM tumors as non-  the etiology of SC neoplasia, they can provide valuable informa-
           painful because of lack of nociceptors in the parenchyma 126,144 ;   tion with respect to hematologic abnormalities, paraneoplastic
           however, in one study that specifically reported on the prevalence   syndromes, and primary organ dysfunction that is often detected
           of paraspinal hyperpathia, 68% of all dogs with IM tumors dis-  in patients with metastatic cancers such as lymphoma and mul-
           played paraspinal hyperpathia. 135  Development of hyperpathia in   tiple myeloma. 132,145
           association with IM tumors may be a result of altered neurotrans-
           mitter modulation association with destruction of the dorsal horn   Diagnostic Imaging
           of the gray matter known as syringomyelic syndrome (see Fig.   Survey radiographs may identify primary vertebral body tumors
           31.6D–F). 135  Another theory postulates that intramedullary mass   (see Fig. 31.5A, E), pathologic fractures, osseous metastases, as
           expansion may lead to stretching of meninges and stimulation of   well as evidence of concurrent malignancy or disease, but are fre-
           nociceptive pathways.                                 quently normal (see Fig. 31.5C). 135,145  In cats, radiographically
             Primary IM tumors have a protracted clinical course compared   apparent lytic lesions are seen more commonly in nonlymphoid
           with metastatic IM neoplasms. 135  Acute decompensation can   neoplasms. 133,138
           occur because of pathologic fracture of neoplastic vertebra, hem-  As with brain tumors, MRI is the modality of choice for the
           orrhage in or around the tumor or SC, or necrosis of the tumor   evaluation of SC tumors. 130–131,135,146,147  However, CT myelogra-
           itself. Clinical signs of SC disease, rather than primary organ dys-  phy can be helpful for determination of the longitudinal and axial
           function, is a frequent chief complaint for animals with second-  location of many neoplastic lesions. 147  Irrespective of the imag-
           ary SC tumors, occurring in up to 44% of dogs with metastatic   ing modality used, in some cases it can be difficult to distinguish
           tumors. 135,140                                       ID-EM from IM origin masses. 146  Similar to what is observed with






















            A                                  B                                  C










                                                                                                *
                                                               *





            D                                  E                                  F

                           • Fig. 31.6  Intradural (A–C) and intramedullary (D–F) canine spinal cord tumors. Dorsal STIR (A) and postcontrast
                           magnetic resonance image (MRI)  (B, C) images of C1 meningioma causing marked spinal cord compression
                           dural tail (A, arrow). Recurrent tumor is visible 9 months after surgery (C). MRI of heterogeneously contrast
                           enhancing (D) and T2 hyperintense (E) grade III oligodendroglioma that effaces the spinal cord architecture at
                           T10. Necropsy specimen demonstrating intramedullary tumor (F, arrow) and syringomyelic cavity (*).
   684   685   686   687   688   689   690   691   692   693   694